Collegium Pharmaceutical, Inc. Intangible Assets, Net (Excluding Goodwill)
Collegium Pharmaceutical, Inc. (COLL) had Intangible Assets, Net (Excluding Goodwill) of $1.19 billion as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2026-08-06
- 2026-06-30: Intangible Assets, Net (Excluding Goodwill) $1.19B.
- 2026-03-31: Intangible Assets, Net (Excluding Goodwill) $614.04M.
- 2025-12-31: Intangible Assets, Net (Excluding Goodwill) $669.51M.
- 2025-09-30: Intangible Assets, Net (Excluding Goodwill) $724.98M.
| Period end | Intangible Assets, Net (Excluding Goodwill) |
|---|---|
| 2026-06-30 | $1.19B 10-Q · filed 2026-08-06 |
| 2026-03-31 | $614.04M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $669.51M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $724.98M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $780.46M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $835.93M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $891.40M 10-K · filed 2026-02-26 |
| 2024-09-30 | $946.88M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $352.68M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $387.19M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $421.71M 10-K · filed 2025-02-27 |
| 2023-09-30 | $456.22M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $492.54M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $530.00M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $567.47M 10-K · filed 2024-02-22 |
| 2022-09-30 | $609.75M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $647.30M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $694.80M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $268.72M 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |